News
In $2B settlement, DuPont agrees to fund remediation at four toxic sites—including the giant Chambers Works facility—but ...
In $2B settlement, DuPont agrees to fund remediation at four toxic sites, including the giant Chambers Works facility, but ...
Chemours Co. and Corteva Inc. — have reached a settlement that will resolve all pending environmental and other claims by the ...
Companies to pay $875 million over 25 years to resolve PFAS pollution claims in New Jersey Settlement adds to growing list of ...
The state of New Jersey said its PFAS settlement with DuPont, Chemours and Corteva is one of historic proportions.
New Jersey reaches historic $2 billion environmental settlement with DuPont over 'forever chemicals'
Three chemical producers have reached a historic settlement with the state of New Jersey over "forever chemicals" and other pollutants released into the environment.
1d
Zacks Investment Research on MSNChemours (CC) Tops Q2 Earnings and Revenue EstimatesChemours (CC) came out with quarterly earnings of $0.58 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.38 per share a year ago. These figures are ...
Chemours reported adjusted earnings of $0.58 a share, surpassing analyst forecasts for $0.46 per share. Revenue came in at $1 ...
The Wilmington, Del.-based chemicals company’s loss was primarily driven by litigation-related charges tied to an ...
The Chemours Company (“Chemours” or “the Company”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (“TSS”), Titanium Technologies (“TT”), and ...
Chemours Co. (CC) on Tuesday reported a second-quarter loss of $381 million, after reporting a profit in the same period a year earlier.
1d
TipRanks on MSNChemours options imply 11.0% move in share price post-earningsPre-earnings options volume in Chemours (CC) is normal with calls leading puts 6:5. Implied volatility suggests the market is anticipating a move ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results